Markus Thieme
Luebeck, SH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Inhibition of Glucose Metabolism Abrogates the Effector Phase of Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.
Journal: The Journal of investigative dermatology
Published: July 28, 2020
Dapsone Suppresses Disease in Preclinical Murine Models of Pemphigoid Diseases.
Journal: The Journal of investigative dermatology
Published: January 15, 2020
Primary Cutaneous Gamma-Delta T-Cell Lymphoma With Long-Term Indolent Clinical Course Initially Mimicking Lupus Erythematosus Profundus.
Journal: Frontiers in oncology
Published: November 12, 2019
First emergence of pyoderma gangraenosum, palmoplantar pustulosis and sacroiliitis in a psoriasis patient associated with switching from secukinumab to brodalumab.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 28, 2019
The Sphingosine-1-Phosphate Receptor Modulator Fingolimod Aggravates Murine Epidermolysis Bullosa Acquisita.
Journal: The Journal of investigative dermatology
Published: October 09, 2018
Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.
Journal: Pharmacology research & perspectives
Published: September 25, 2017
Pharmacologic Treatment Assigned for Niemann Pick Type C1 Disease Partly Changes Behavioral Traits in Wild-Type Mice.
Journal: International journal of molecular sciences
Published: September 26, 2016
Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation.
Journal: Experimental dermatology
Published: August 26, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026